ENTERPRISE THERAPEUTICS
Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.
ENTERPRISE THERAPEUTICS
Social Links:
Industry:
Health Care Health Diagnostics Therapeutics
Founded:
2014-01-01
Address:
Falmer, East Sussex, United Kingdom
Country:
United Kingdom
Website Url:
http://www.enterprisetherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
44 7765 220 733
Email Addresses:
[email protected]
Total Funding:
42.8 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Auris Medical
Auris Medical develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.
Current Employees Featured
Founder
Investors List
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation investment in Grant - Enterprise Therapeutics
IP Group
IP Group investment in Series B - Enterprise Therapeutics
Forbion Capital Partners
Forbion Capital Partners investment in Series B - Enterprise Therapeutics
Versant Ventures
Versant Ventures investment in Series B - Enterprise Therapeutics
Epidarex Capital
Epidarex Capital investment in Series B - Enterprise Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series B - Enterprise Therapeutics
Cystic Fibrosis Trust
Cystic Fibrosis Trust investment in Grant - Enterprise Therapeutics
Imperial Innovations
Imperial Innovations investment in Venture Round - Enterprise Therapeutics
Epidarex Capital
Epidarex Capital investment in Venture Round - Enterprise Therapeutics
Imperial Innovations
Imperial Innovations investment in Series A - Enterprise Therapeutics
Key Employee Changes
Date | New article |
---|---|
2022-02-09 | Enterprise Therapeutics appoints chief medical officer |
2020-02-10 | Enterprise Therapeutics nabs Novartis VC exec as new CMO |
Official Site Inspections
http://www.enterprisetherapeutics.com
- Host name: 109.69.238.113
- IP address: 109.69.238.113
- Location: Dronfield United Kingdom
- Latitude: 53.2988
- Longitude: -1.4637
- Timezone: Europe/London
- Postal: S18